A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 38/19 (2006.01) A61K 39/395 (2006.01) C07K 16/00 (2006.01) C07K 16/22 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2361615
The present invention is directed to VEGF-2 polynucleotides and polypeptides and methods of using such polynucleotides and polypeptides. In particular, provided are methods of treating retinal disorders with VEGF-2 polynucleotides and polypeptides.
L'invention concerne des polynucléotides et des polypeptides de VEGF-2, ainsi que des procédés d'utilisation de ces polynucléotides et de ces polypeptides. Elle concerne, en particulier des procédés de traitement de troubles rétiniens au moyen de polynucléotides et de polypeptides de VEGF-2.
Alderson Ralph
Melder Robert
Roschke Viktor
Rosen Craig A.
Ruben Steven M.
Human Genome Sciences Inc.
Mbm Intellectual Property Law Llp
LandOfFree
The use of vascular endothelial growth factor 2 antagonist... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The use of vascular endothelial growth factor 2 antagonist..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of vascular endothelial growth factor 2 antagonist... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1877226